Hyderabad : MSN Pharmaceuticals Inc. (MSNPI), a wholly-owned subsidiary of MSN Group of Companies, based out of Piscataway, New Jersey, USA successfully completed its maiden USFDA audit with zero observations.

The state-of-the-art finished dosages facility was established to bolster MSN Group’s product portfolio as well as Contract Development & Manufacturing services, in the US and several other key regulatory markets.

“This is a major accomplishment for us. It augments the core strategy of establishing ourselves as a preferred Contract Development & Manufacturing Service provider globally, offering end-to-end drug manufacturing services.  Also, besides helping us to deepen our presence in the US market, it will enable us to make high-quality generics affordable and accessible to the patients swiftly and efficiently.” MSN Group commented on the occasion.

Backed by novel technologies and innovative R&D expertise, MSN Pharmaceuticals Inc. is well-equipped to deliver complex and high-quality pharmaceutical products in General and DEA Controlled categories. In addition, the world-class production and backward integration capabilities help in efficiently catering to large-scale commercial volumes of Made-In-America Pharmaceutical products.